|1.||Saito, Mitsuru: 6 articles (07/2010 - 12/2006)|
|2.||Shin, Jae Il: 5 articles (07/2014 - 01/2007)|
|3.||DCCT/EDIC Research Group: 4 articles (01/2014 - 01/2014)|
|4.||World Health Organization: 4 articles (01/2013 - 01/2012)|
|5.||Cengiz, Mustafa: 4 articles (03/2010 - 08/2006)|
|6.||Mayr, Nina A: 4 articles (08/2008 - 01/2005)|
|7.||Wang, Jian Z: 4 articles (08/2008 - 01/2005)|
|8.||Sjölander, Anita: 4 articles (12/2006 - 03/2003)|
|9.||Myer, Gregory D: 3 articles (05/2015 - 11/2011)|
|10.||Faigenbaum, Avery D: 3 articles (05/2015 - 11/2011)|
05/01/2015 - "A two-stage protocol with the temporary insertion of an antibiotic-laden cement spacer is the gold standard treatment for chronic infections (Clinics (Sao Paulo) 62:99-108, 2007; Clin Orthop Relat Res 427:37-46, 2004; J Arthroplast 14:175-181, 1999; Clin Orthop Relat Res 467:1848-1858, 2009; J Arthroplast 20:874-879, 2005; J Arthroplast 24: 607-613, 2009; Clin Orthop Relat Res 469:1009-1015, 2011; Hip Int 20:26-33, 2010; J Arthroplast 24:1051-1060, 2009; J Bone Joint Surg Br 91:44-51, 2009). "
05/01/2015 - "Some authors, however (Int J Med Sci 6(5):265-73, 2009), report mechanical complication rates with spacers in excess of 50%.Therefore, the aim of this study is to determine (1) the mechanical complications associated with enclosed articulating partial load-bearing spacers when treating periprosthetic hip infections and (2) possible factors of influence. "
03/01/2012 - "This study aimed to identify the characteristics of recombinant-adenovirus-modified PBMC-derived dendritic cells and their resistance to HIV-1 infection by integrating the CCR5∆32, CCR5siRNA, HIV-1 pol and HIV-1 int genes into a recombinant adenovirus vector using the AdEasy system. "
10/01/2006 - "INT consisted of an infection manager who worked closely with nephrologists and dialysis staff and made treatment recommendations using the available published guidelines at the time of the study's conception (Dialysis Outcomes Quality Initiative guideline no. 26, 1997) and additional literature-based recommendations. "
09/01/2006 - "Studies were carried out in a human intestinal cell line (Int 407) and a murine macrophage cell line (P388D1) in order to evaluate its potency in local as well as systemic infections. "
01/01/2015 - "At the end of the PASSAGE Program, the percentages of patients who perceived overall improvement in their pain levels, functioning and quality of life were significantly higher in the INT Group (73%, 55%, 77% respectively) than in the WL Group (8%, 12%, 20%). "
01/01/2015 - "We also searched ClinicalTrials.gov (http://clinicaltrials.gov/; metaRegister of Controlled Trials (mRCT) (http://www.controlled-trials.com/mrct/), the World Health Organization (WHO) International Clinical Trials Registry Platform (ICTRP) search portal (http://apps.who.int/trialsearch/) and the Proceedings of the Congress of the European Federation of International Association for the Study of Pain (IASP; via European Journal of Pain Supplements) on 16 February 2015. "
01/01/2014 - "We searched the Cochrane Central Register of Controlled Trials (CENTRAL) in The Cochrane Library, MEDLINE, EMBASE, and the Oxford Pain Relief Database, together with three online databases (www.astrazenecaclinicaltrials.com, www.clinicaltrials.gov, and apps.who.int/trialsearch) for studies to 12 March 2014. "
06/01/2011 - "The purpose of this study was to evaluate how interval (INT) and continuous (CONT) cycle ergometry alter thermal sensation, hand pain, mean finger temperature, and skin surface temperature gradient (forearm-finger) following immobility in moderate cold. "
12/01/2003 - "Analysis of variance showed significant differences between GDX and INT animals depending on the trial considered: Trial 1: the GDX and INT groups showed a similar amount of licking, flexing, and paw-jerk; Trials 2 and 3: these responses showed a sort of adaptation in INT animals, not present in the GDX ones, resulting in lower levels of pain responses in INT than GDX. "
|3.||Asthma (Bronchial Asthma)
12/01/2005 - "Significant improvement in asthma knowledge was noted for INT parents and young INT children at follow-up (Parent: CON = 16.3; INT = 17.5, p < 0.001; Young children: CON = 10.8, INT = 12.45, p < 0.001). "
11/01/2010 - "These data suggest that CD11b(+)Gr1(int)F4/80(+) cells contribute to the protective effects of LPS in allergic asthma by tempering Th2 effector function in the tissue."
06/01/2014 - "The objective of this study was to test the efficacy of a clinician and caregiver feedback intervention (INT) on improving preventive asthma care following an asthma ED visit compared to an attention control group (CON). "
04/01/1992 - "The purpose of this study was to determine if a brief educational intervention (INT) on the treatment of acute asthma improved prescribing patterns of internal medicine residents in an emergency department (ED). "
01/01/2007 - "The aim of our study was to determine the effects of anti-asthma treatment in children, equally on FEV(1), FEF25-75%, R(int) and SR(aw) values. "
|4.||Body Weight (Weight, Body)
06/01/2007 - "Among secondary outcomes, between-group differences were significantly greater (P<0.05) for INT in mean body weight (-1.60 kg), waist circumference (-1.8 cm), triglyceride (-7 mg.dL), hsCRP (-0.063 mg.L), and estimated VO2peak (2.0 mL.kg.min). "
12/01/2003 - "Subjects in the INT reduced their body weight, waist circumference, and (saturated) fat intake and improved their aerobic capacity. "
01/01/2015 - "The aims of this study were to quantify additive genetic variance for ES of body weight (BW), defined as the slope of reaction norm across breeding environment (BE) and production environment (PE), and to estimate the genetic correlation (rg(int, sl)) between BW and ES. "
03/01/2015 - "However, the gene expression profiles of INT-exposed mice differed to those of CR-exposed mice and showed to be more similar with those of C- and MF-exposed mice with a comparable body weight. "
03/01/2014 - "The INT was performed 2 times per week during the first approximately 15 minutes of each PE class and consisted of body weight exercises. "
11/01/2004 - "Improved disease free and overall survivals were seen in curatively resected patients with gastric and gastroesophageal adenocarcinoma treated with the Intergroup 0116 (INT 0116) protocol of postoperative adjuvant chemoradiotherapy compared to surgery alone. "
08/15/2014 - "The randomized adjuvant chemoradiation (CRT) trial, intergroup trial (INT 0116) enrolled 559 patients with resected adenocarcinoma of the stomach or gastroesophageal junction. "
07/01/2013 - "Assessment of HER2 gene amplification in adenocarcinomas of the stomach or gastroesophageal junction in the INT-0116/SWOG9008 clinical trial."
11/01/2004 - "The INT 0116 protocol is a safe and feasible schedule in a multicentre setting with an acceptable rate of toxicity and is an appropriate adjuvant treatment option for high-risk resected gastroesophageal adenocarcinoma."
12/01/1998 - "Integration of mouse mammary tumor virus (MMTV) near the int genes results in the inappropriate expression of these proto-oncogenes and initiates events that lead to the formation of mammary adenocarcinomas. "
|2.||Azacitidine (5 Azacytidine)
|6.||Biological Markers (Surrogate Marker)
|7.||Advanced Glycosylation End Products
|9.||Morphine (MS Contin)
|1.||Drug Therapy (Chemotherapy)
|5.||Knee Replacement Arthroplasty (Total Knee Replacement)